http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107982356-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-538 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107982356-B |
| titleOfInvention | Oral medicine for treating respiratory tract infection |
| abstract | An oral medicine for treating respiratory tract infection is a medicament prepared by traditional Chinese medicine raw materials of 10-30 parts of fructus forsythiae, 5-25 parts of lonicera confusa, 5-20 parts of schizonepeta, 5-20 parts of mulberry leaf, 5-25 parts of radix bupleuri, 5-20 parts of scutellaria baicalensis, 10-25 parts of folium isatidis, 5-20 parts of fructus viticis, 5-20 parts of burdock and 1-10 parts of liquorice according to a conventional preparation method. The drug effect test shows that the drug can inhibit and kill common pathogenic bacteria and viruses of respiratory tract infection in vitro, block the infection of the viruses to cells and inhibit the proliferation of the viruses in the cells; can inhibit the infection of bacteria and viruses in mice and reduce the lung inflammation caused by the infection of bacteria and viruses; the composition has obvious antipyretic effect on rabbit fever models caused by typhoid fever and paratyphoid fever; the anti-inflammatory effect on a mouse peritoneal capillary permeability model and the anti-inflammatory effect on a mouse auricle swelling model caused by xylene are obvious; and has significant analgesic effect. |
| priorityDate | 2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.